Induction of Hsp90 hyperacetylation to dissociate with its binding proteins is identified in HDACs inhibitor‐treated cancer cells (Kovacs et al., 2005; Liou, Hua, Hsu, & Weng, 2015; Park et al., 2008). Here, HSP90AA1 is linked to cancer.